Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases

Abstract

Cardiovascular diseases (CVD) are the leading cause of death and morbidity in the world and are a major contributor to healthcare costs. Although enormous progress has been made in diagnosing CVD, there is an urgent need for more efficient early detection and the development of novel diagnostic tools. Currently, CVD diagnosis relies primarily on clinical symptoms based on molecular imaging (MOI) or biomarkers associated with CVDs. However, sensitivity, specificity, and accuracy of the assay are still challenging for early-stage CVDs. Nanomaterial platform has been identified as a promising candidate for improving the practical usage of diagnostic tools because of their unique physicochemical properties. In this review article, we introduced cardiac biomarkers and imaging techniques that are currently used for CVD diagnosis. We presented the applications of various nanotechnologies on diagnosis within cardiac immunoassays (CIAs) and molecular imaging. We also summarized and compared different cardiac immunoassays based on their sensitivities and working ranges of biomarkers.

Boosted EfficientNet: Detection of Lymph Node Metastases in Breast Cancer Using Convolutional Neural Networks

“…Moreover, the majority of the population often has difficulty getting access to pathology and laboratory medicine services. Regarding cancer, cardiovascular disease, and bone generation as examples, few communities can get the pathology and laboratory medicine treatment [16][17][18][19][20][21].…”

“…Moreover, the majority of the population can barely get access to pathology and laboratory medicine services. Take cancer and cardiovascular disease as examples, only a few and unbalanced communities can get the PLAM treatment [14][15][16] .…”

Nanotechnology for cardiovascular diseases

“…Protein targets are first sensed by recognition molecules such as antibodies, aptamers, or molecularly imprinted polymers, and the sensing is then quantitatively detected by various methods, including electrochemistry (EC), electrochemiluminescence (ECL), fluorescent methods (FL), colorimetry, surface-enhanced Raman scattering (SERS), and surface plasmon resonance technology (SPR). 33 Nanomaterials with excellent optoelectronic properties greatly improve the detection sensitivity by orders of magnitude. 21 , 34 , 35 , 36 , 37 , 38 With ZnSnO 3 perovskite nanomaterial-decorated glassy carbon electrodes, Singh et al.…”

Advanced Immunotherapy Approaches for Glioblastoma

“…Moreover, EVs‐based therapeutics against cancer is being challenged due to inadequate secretion and low potency of drug payload for desirable anti‐tumor efficacy. [ 78,79 ] Due to the aforementioned limitation, multiple strategies have been developed for EVs mass production and to involve a substantial amount of therapeutic agents into EVs. For instance, Ryosuke et al.…”